RNA vs ABT
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 19, 2026
RNA
ABT
Investment Advisor Scores
ABT
AI Analyst Insights
Detailed Metrics Comparison
| Metric | RNA | ABT | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 17.094 | Tie |
| PEG Ratio | 0 | 1.8991 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -21.9% | 13.0% | ABT |
| Earnings Growth | 0.0% | -47.5% | RNA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 74.9/100 | 51.6/100 | RNA |
| Profit Margin | -184.1% | 11.7% | ABT |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
RNA
MarkdownPrice below a falling SMA50 (slope -12.0%), weak momentum, RSI 30
ABT
NeutralMixed signals - no dominant trend phase, RSI 59
Fundamentals Snapshot
| Metric | RNA | ABT |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -1.2 | 17.3 |
| Trailing P/E | — | 33.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.2% | 0.1% |
| Gross Margin | -0.6% | 0.6% |
| Operating Margin | -7.5% | 0.1% |
| EPS | -5.37 | 3.10 |
| Dividend Yield | — | 0.02% |